Literature DB >> 20051218

Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy.

Bogata D Bundy1, Walter Hewer, Franz-Josef Andres, Peter Gass, Alexander Sartorius.   

Abstract

OBJECTIVE: Electroconvulsive therapy (ECT) is performed under anesthesia and muscle relaxation. Only well-generalized seizures seem to have the high "adequacy" or "quality" that have been claimed to reflect positive predictive power for the outcome of an ECT course. The induction of well-generalized seizures can be potentially influenced by several variables. One major variable is concurrent medication including anesthetic drugs, since most anesthetic drugs are potent anticonvulsives. We hypothesized a negative influence of anesthetics and benzodiazepines but a positive effect of antidepressants and antipsychotics concurrently applied during ECT on seizure adequacy.
METHOD: We included inpatients (n = 41) with a DSM-IV-diagnosed major depressive episode treated with ECT (411 ECT sessions) during a period of 20 months (May 2005 to December 2006) in an open label and noncontrolled study. A repeated measurement regression analysis was performed with 8 seizure adequacy parameters as dependent variables. We indirectly quantified narcotic agent influence with bispectral index monitoring.
RESULTS: In contrast to the impact of psychiatric comedication, this measure of "depth of narcosis" prior stimulation turned out to influence most seizure adequacy parameters in a highly significant manner.
CONCLUSIONS: Thus, we concluded that the anticonvulsive properties of narcotic agents have much higher influence than concomitant psychotropic medication. Our data support the view that a significant influence of concurrent psychotropic drugs on seizure adequacy markers is missing, especially when directly compared with other confounders like stimulation energy, age, and depth of narcosis. The latter suggests to further prove the idea that lighter anesthesia is indeed an important tool to get patients faster into remission. 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20051218     DOI: 10.4088/JCP.08m04971gre

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

1.  ECT seizure quality and serum BDNF, revisited.

Authors:  Alexander Sartorius; Jan Malte Bumb; Suna Su Aksay; Peter Gass; Rainer Hellweg; Laura Kranaster
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-05       Impact factor: 5.270

2.  S -ketamine compared to etomidate during electroconvulsive therapy in major depression.

Authors:  Maxim Zavorotnyy; Ina Kluge; Kathrin Ahrens; Thomas Wohltmann; Benjamin Köhnlein; Patricia Dietsche; Udo Dannlowski; Tilo Kircher; Carsten Konrad
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-19       Impact factor: 5.270

3.  [Ketamine as anesthetic agent in electroconvulsion therapy].

Authors:  C Janke; J M Bumb; S S Aksay; M Thiel; L Kranaster; A Sartorius
Journal:  Anaesthesist       Date:  2015-05-06       Impact factor: 1.041

4.  Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study.

Authors:  Carolin Hoyer; Laura Kranaster; Christoph Janke; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

5.  Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.

Authors:  Jan Malte Bumb; Suna Su Aksay; Christoph Janke; Laura Kranaster; Olga Geisel; Peter Gass; Rainer Hellweg; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-18       Impact factor: 5.270

6.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

7.  Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.

Authors:  Laura Kranaster; Jutta Kammerer-Ciernioch; Carolin Hoyer; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-13       Impact factor: 5.270

8.  Does remifentanil improve ECT seizure quality?

Authors:  Verònica Gálvez; Phern-Chern Tor; Adriana Bassa; Dusan Hadzi-Pavlovic; Ross MacPherson; Mincho Marroquin-Harris; Colleen K Loo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-01       Impact factor: 5.270

9.  Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study.

Authors:  Jeroen A van Waarde; Lucas J B van Oudheusden; Bastiaan Verwey; Erik J Giltay; Rose C van der Mast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-15       Impact factor: 5.270

10.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.